000 | 01708 a2200481 4500 | ||
---|---|---|---|
005 | 20250516114035.0 | ||
264 | 0 | _c20130516 | |
008 | 201305s 0 0 eng d | ||
022 | _a1756-2651 | ||
024 | 7 |
_a10.1093/jb/mvs112 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTanaka, Kyoko | |
245 | 0 | 0 |
_aPossible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells. _h[electronic resource] |
260 |
_bJournal of biochemistry _cDec 2012 |
||
300 |
_a587-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
650 | 0 | 4 |
_aCell Line, Tumor _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCholesterol _xmetabolism |
650 | 0 | 4 |
_aCisplatin _xpharmacology |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycolipids _xmetabolism |
650 | 0 | 4 |
_aGlycosyltransferases _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 |
_aMorpholines _xpharmacology |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xgenetics |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
650 | 0 | 4 |
_aPhospholipids _xmetabolism |
650 | 0 | 4 |
_aSialyltransferases _xmetabolism |
700 | 1 | _aTakada, Hidetaka | |
700 | 1 | _aIsonishi, Seiji | |
700 | 1 | _aAoki, Daisuke | |
700 | 1 | _aMikami, Mikio | |
700 | 1 | _aKiguchi, Kazushige | |
700 | 1 | _aIwamori, Masao | |
773 | 0 |
_tJournal of biochemistry _gvol. 152 _gno. 6 _gp. 587-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jb/mvs112 _zAvailable from publisher's website |
999 |
_c22160498 _d22160498 |